Elegance Optical International Holdings Limited (HKG:0907)
Hong Kong · Delayed Price · Currency is HKD 0.0540
0.00 (0.00%)
Oct 23, 2025, 4:08 PM HKT
HKG:0907 Revenue
In the fiscal year ending March 31, 2025, Elegance Optical International Holdings had annual revenue of 14.46M HKD, down -39.73%. Elegance Optical International Holdings had revenue of 7.36M in the half year ending March 31, 2025.
Revenue
14.46M
Revenue Growth
-39.73%
P/S Ratio
3.26
Revenue / Employee
578.28K
Employees
25
Market Cap
47.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 14.46M | -9.53M | -39.73% |
| Mar 31, 2024 | 23.99M | 2.29M | 10.53% |
| Mar 31, 2023 | 21.70M | 6.43M | 42.09% |
| Mar 31, 2022 | 15.28M | -38.66M | -71.68% |
| Mar 31, 2021 | 53.93M | -12.32M | -18.59% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |